Ferro Pfanstiehl is a leading technology-based provider of specialized products and services for niche pharmaceutical and biotechnological applications. Pfanstiehl produces commercial quantities of high-purity, low-endotoxin sugars utilized as injectable excipients.
This attention-grabbing visual identity introduces and dramatizes the advantages of its ICH-Q7A-compliant sugars for stabilizing freeze-dried therapeutic proteins used in injectables. Most protein-based bio-pharmaceuticals must be injected and demand a much higher level of purity. The visuals are clean and technical to reflect the appropriate tonality and presence within the pharmaceutical market. The central images of a syringe contrasted against a spoonful of sugar-coated cereal and the headline that focused on safety concerns created a disruptive identity.
This attention-grabbing visual identity introduces and dramatizes the advantages of its ICH-Q7A-compliant sugars for stabilizing freeze-dried therapeutic proteins used in injectables. Most protein-based bio-pharmaceuticals must be injected and demand a much higher level of purity. The visuals are clean and technical to reflect the appropriate tonality and presence within the pharmaceutical market. The central images of a syringe contrasted against a spoonful of sugar-coated cereal and the headline that focused on safety concerns created a disruptive identity.
Identity_Logo
Print_Trade Ad
Print_Exhibit
AWARDS
2003 Pharma Choice Award
Best Pharmaceuticals Integrated Ad Campaign
Ferro Pfanstiehl Injectable Sugars
Client: Ferro Pfanstiehl
Agency: The Bridge, Creative Services
